1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global High Flux Hemodialyzer Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for High Flux Hemodialyzer by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for High Flux Hemodialyzer by Country/Region, 2018, 2022 & 2029
2.2 High Flux Hemodialyzer Segment by Type
2.2.1 20-30ml/h
2.2.2 Over 30ml/h
2.3 High Flux Hemodialyzer Sales by Type
2.3.1 Global High Flux Hemodialyzer Sales Market Share by Type (2018-2023)
2.3.2 Global High Flux Hemodialyzer Revenue and Market Share by Type (2018-2023)
2.3.3 Global High Flux Hemodialyzer Sale Price by Type (2018-2023)
2.4 High Flux Hemodialyzer Segment by Application
2.4.1 Hospitals
2.4.2 Clinic Centers
2.4.3 Others
2.5 High Flux Hemodialyzer Sales by Application
2.5.1 Global High Flux Hemodialyzer Sale Market Share by Application (2018-2023)
2.5.2 Global High Flux Hemodialyzer Revenue and Market Share by Application (2018-2023)
2.5.3 Global High Flux Hemodialyzer Sale Price by Application (2018-2023)
3 Global High Flux Hemodialyzer by Company
3.1 Global High Flux Hemodialyzer Breakdown Data by Company
3.1.1 Global High Flux Hemodialyzer Annual Sales by Company (2018-2023)
3.1.2 Global High Flux Hemodialyzer Sales Market Share by Company (2018-2023)
3.2 Global High Flux Hemodialyzer Annual Revenue by Company (2018-2023)
3.2.1 Global High Flux Hemodialyzer Revenue by Company (2018-2023)
3.2.2 Global High Flux Hemodialyzer Revenue Market Share by Company (2018-2023)
3.3 Global High Flux Hemodialyzer Sale Price by Company
3.4 Key Manufacturers High Flux Hemodialyzer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers High Flux Hemodialyzer Product Location Distribution
3.4.2 Players High Flux Hemodialyzer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for High Flux Hemodialyzer by Geographic Region
4.1 World Historic High Flux Hemodialyzer Market Size by Geographic Region (2018-2023)
4.1.1 Global High Flux Hemodialyzer Annual Sales by Geographic Region (2018-2023)
4.1.2 Global High Flux Hemodialyzer Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic High Flux Hemodialyzer Market Size by Country/Region (2018-2023)
4.2.1 Global High Flux Hemodialyzer Annual Sales by Country/Region (2018-2023)
4.2.2 Global High Flux Hemodialyzer Annual Revenue by Country/Region (2018-2023)
4.3 Americas High Flux Hemodialyzer Sales Growth
4.4 APAC High Flux Hemodialyzer Sales Growth
4.5 Europe High Flux Hemodialyzer Sales Growth
4.6 Middle East & Africa High Flux Hemodialyzer Sales Growth
5 Americas
5.1 Americas High Flux Hemodialyzer Sales by Country
5.1.1 Americas High Flux Hemodialyzer Sales by Country (2018-2023)
5.1.2 Americas High Flux Hemodialyzer Revenue by Country (2018-2023)
5.2 Americas High Flux Hemodialyzer Sales by Type
5.3 Americas High Flux Hemodialyzer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC High Flux Hemodialyzer Sales by Region
6.1.1 APAC High Flux Hemodialyzer Sales by Region (2018-2023)
6.1.2 APAC High Flux Hemodialyzer Revenue by Region (2018-2023)
6.2 APAC High Flux Hemodialyzer Sales by Type
6.3 APAC High Flux Hemodialyzer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe High Flux Hemodialyzer by Country
7.1.1 Europe High Flux Hemodialyzer Sales by Country (2018-2023)
7.1.2 Europe High Flux Hemodialyzer Revenue by Country (2018-2023)
7.2 Europe High Flux Hemodialyzer Sales by Type
7.3 Europe High Flux Hemodialyzer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa High Flux Hemodialyzer by Country
8.1.1 Middle East & Africa High Flux Hemodialyzer Sales by Country (2018-2023)
8.1.2 Middle East & Africa High Flux Hemodialyzer Revenue by Country (2018-2023)
8.2 Middle East & Africa High Flux Hemodialyzer Sales by Type
8.3 Middle East & Africa High Flux Hemodialyzer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of High Flux Hemodialyzer
10.3 Manufacturing Process Analysis of High Flux Hemodialyzer
10.4 Industry Chain Structure of High Flux Hemodialyzer
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 High Flux Hemodialyzer Distributors
11.3 High Flux Hemodialyzer Customer
12 World Forecast Review for High Flux Hemodialyzer by Geographic Region
12.1 Global High Flux Hemodialyzer Market Size Forecast by Region
12.1.1 Global High Flux Hemodialyzer Forecast by Region (2024-2029)
12.1.2 Global High Flux Hemodialyzer Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global High Flux Hemodialyzer Forecast by Type
12.7 Global High Flux Hemodialyzer Forecast by Application
13 Key Players Analysis
13.1 Dialife SA
13.1.1 Dialife SA Company Information
13.1.2 Dialife SA High Flux Hemodialyzer Product Portfolios and Specifications
13.1.3 Dialife SA High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Dialife SA Main Business Overview
13.1.5 Dialife SA Latest Developments
13.2 Asahi Kasei Corporation
13.2.1 Asahi Kasei Corporation Company Information
13.2.2 Asahi Kasei Corporation High Flux Hemodialyzer Product Portfolios and Specifications
13.2.3 Asahi Kasei Corporation High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Asahi Kasei Corporation Main Business Overview
13.2.5 Asahi Kasei Corporation Latest Developments
13.3 B. Braun Melsungen AG
13.3.1 B. Braun Melsungen AG Company Information
13.3.2 B. Braun Melsungen AG High Flux Hemodialyzer Product Portfolios and Specifications
13.3.3 B. Braun Melsungen AG High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 B. Braun Melsungen AG Main Business Overview
13.3.5 B. Braun Melsungen AG Latest Developments
13.4 Medica S.p.A.
13.4.1 Medica S.p.A. Company Information
13.4.2 Medica S.p.A. High Flux Hemodialyzer Product Portfolios and Specifications
13.4.3 Medica S.p.A. High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Medica S.p.A. Main Business Overview
13.4.5 Medica S.p.A. Latest Developments
13.5 Baxter International Inc
13.5.1 Baxter International Inc Company Information
13.5.2 Baxter International Inc High Flux Hemodialyzer Product Portfolios and Specifications
13.5.3 Baxter International Inc High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Baxter International Inc Main Business Overview
13.5.5 Baxter International Inc Latest Developments
13.6 Cantel Medical Corporation (Steris plc)
13.6.1 Cantel Medical Corporation (Steris plc) Company Information
13.6.2 Cantel Medical Corporation (Steris plc) High Flux Hemodialyzer Product Portfolios and Specifications
13.6.3 Cantel Medical Corporation (Steris plc) High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cantel Medical Corporation (Steris plc) Main Business Overview
13.6.5 Cantel Medical Corporation (Steris plc) Latest Developments
13.7 Medtronic PLC
13.7.1 Medtronic PLC Company Information
13.7.2 Medtronic PLC High Flux Hemodialyzer Product Portfolios and Specifications
13.7.3 Medtronic PLC High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Medtronic PLC Main Business Overview
13.7.5 Medtronic PLC Latest Developments
13.8 Browndove Healthcare (P) Ltd.
13.8.1 Browndove Healthcare (P) Ltd. Company Information
13.8.2 Browndove Healthcare (P) Ltd. High Flux Hemodialyzer Product Portfolios and Specifications
13.8.3 Browndove Healthcare (P) Ltd. High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Browndove Healthcare (P) Ltd. Main Business Overview
13.8.5 Browndove Healthcare (P) Ltd. Latest Developments
13.9 Kayren Medical and Health Services
13.9.1 Kayren Medical and Health Services Company Information
13.9.2 Kayren Medical and Health Services High Flux Hemodialyzer Product Portfolios and Specifications
13.9.3 Kayren Medical and Health Services High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Kayren Medical and Health Services Main Business Overview
13.9.5 Kayren Medical and Health Services Latest Developments
13.10 Nipro Corporation
13.10.1 Nipro Corporation Company Information
13.10.2 Nipro Corporation High Flux Hemodialyzer Product Portfolios and Specifications
13.10.3 Nipro Corporation High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nipro Corporation Main Business Overview
13.10.5 Nipro Corporation Latest Developments
13.11 Toray Industries Inc.
13.11.1 Toray Industries Inc. Company Information
13.11.2 Toray Industries Inc. High Flux Hemodialyzer Product Portfolios and Specifications
13.11.3 Toray Industries Inc. High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Toray Industries Inc. Main Business Overview
13.11.5 Toray Industries Inc. Latest Developments
13.12 Farmasol
13.12.1 Farmasol Company Information
13.12.2 Farmasol High Flux Hemodialyzer Product Portfolios and Specifications
13.12.3 Farmasol High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Farmasol Main Business Overview
13.12.5 Farmasol Latest Developments
13.13 Nikkiso Co. Ltd.
13.13.1 Nikkiso Co. Ltd. Company Information
13.13.2 Nikkiso Co. Ltd. High Flux Hemodialyzer Product Portfolios and Specifications
13.13.3 Nikkiso Co. Ltd. High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Nikkiso Co. Ltd. Main Business Overview
13.13.5 Nikkiso Co. Ltd. Latest Developments
13.14 Shandong Weigao Group Medical Polymer Co. Ltd.
13.14.1 Shandong Weigao Group Medical Polymer Co. Ltd. Company Information
13.14.2 Shandong Weigao Group Medical Polymer Co. Ltd. High Flux Hemodialyzer Product Portfolios and Specifications
13.14.3 Shandong Weigao Group Medical Polymer Co. Ltd. High Flux Hemodialyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shandong Weigao Group Medical Polymer Co. Ltd. Main Business Overview
13.14.5 Shandong Weigao Group Medical Polymer Co. Ltd. Latest Developments
14 Research Findings and Conclusion
※参考情報 高流束血液透析装置は、慢性腎不全や急性腎障害を持つ患者の血液を効果的に浄化するために設計された医療機器です。透析は、腎臓が正常に機能しない際に、体内の老廃物や余分な水分を除去する手段として広く利用されています。ここでは、高流束血液透析装置の概念について、定義、特徴、種類、用途、関連技術などを解説いたします。 まず、高流束血液透析装置の定義について触れます。高流束とは、透析膜を通過させる流体の流量が高いことを示します。具体的には、透析膜の孔径が大きく、分子の大きさに応じてより多くの毒素を除去できる特性を持っています。高流束透析は、一般的な透析よりも効率的に溶質を除去し、特に中小サイズの分子質(如、β2-ミクログロブリンなど)の除去に優れています。このため、高流束血液透析装置は、より多くの患者に対してより良好な治療結果を提供することができるのです。 高流束血液透析の特徴には、いくつかのポイントがあります。まず一つ目は、高い浄化能力です。通常の透析装置と比較して、より速い速度で血液中の毒素を除去できるため、患者の体内環境を改善するのに効果的です。次に、透析にかかる時間の短縮も言及すべきでしょう。高流束透析は、短時間でも効果的な治療が可能であるため、患者の通院負担を軽減することができます。また、血液透析においては、患者の体重や水分状態を考慮しながら脱水を行う必要がありますが、高流束透析はその際の水分解析の精度も向上させている点が特徴です。 高流束血液透析装置の種類は多岐にわたりますが、大きく分けると、膜型、カプセル型、再生可能型などがあります。膜型は、一般的に使用される透析器で、特定のポリマーを用いた膜を通して血液と透析液が接触します。カプセル型は、特に家庭でも利用されることがあり、そのコンパクトなデザインが特徴的です。再生可能型は、膜の洗浄や再利用が可能で、環境負荷を軽減することに貢献しています。 高流束血液透析装置の用途は、主に末期腎不全患者の治療です。透析治療が必要な患者は、血液中の老廃物を除去し、電解質バランスを保持する必要があります。高流束透析は、これらの目的に特化しており、より効果的に腎不全によるさまざまな合併症を防ぐことが期待されています。また、高流束透析は、急性腎不全患者においても有効であり、治療効果の早期向上が期待されます。 関連技術としては、透析用膜の開発や、透析液の構成に関する技術が挙げられます。近年では、生体適合性の高い素材を用いた膜の研究が進んでおり、より高い透析性能の実現が期待されています。また、透析液の組成やpH、濃度などを最適化することで、さらなる治療効果の向上が図れます。最近の進展としては、ナノテクノロジーを駆使した膜材料の開発や、AIを活用した透析のモニタリング技術の導入などがあり、将来的にはより個別化された透析治療が実現する可能性が高まっています。 総じて、高流束血液透析装置は、腎不全患者にとって生命を維持するために不可欠な医療機器であり、その技術は日々進化しております。患者のQOL(Quality of Life)を向上させるために、効率的かつ効果的な透析治療を提供することが、高流束透析装置の重要な使命であります。今後も技術革新が進み、さらなる治療法の改善が期待される中で、高流束血液透析装置の役割はますます重要になることでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/